← Leaderboards
Nancy Logan Haigwood
University Of Washington
$37,253,957
Attributed
$37,673,933
Total exposure
48
Grants
40
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,785,085 · 49
By mechanism
R01$20,723,755 · 5
P01$16,090,475 · 4
P51$5,482,091 · 32
C06$4,999,996 · 2
P30$1,198,005 · 2
G20$986,647 · 2
Top collaborators
- Jing Wen1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Grace C John-Stewart$42,921,726
- Jairam Rao Lingappa$17,018,282
- Kristina M Adams Waldorf$20,913,441
- Andrew Atwell Oberst$17,614,781
- Joshua Woodward$10,445,693
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyResponseInfectionDesignFundingNonhuman PrimateMacacaGrantImmunityResearch PersonnelUnited States National Institutes Of HealthBaseVirusSimian Human Immunodeficiency VirusViralPrimatesPerinatalAntibodiesSourceVaccinesNewborn InfantResourcesImmunoglobulin GImmune Response
Grant awards (97)
Improved delivery of bNAbs for targeting CNS infection in infants$839,952
R01 · FY2025 · NS
Reducing Latent Viral Reservoirs in Infant Macaques$859,479
R01 · FY2024 · HD · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$860,650
R01 · FY2023 · HD · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$857,506
R01 · FY2022 · HD · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$858,801
R01 · FY2021 · HD · contact PI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE$740,564
R01 · FY2021 · AI · contact PI
ONPRC PENS Expansion$2,000,000
C06 · FY2020 · OD · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$851,722
R01 · FY2020 · HD · contact PI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE$797,395
R01 · FY2020 · AI · contact PI
38th Annual Symposium on Nonhuman Primate Models for AIDS$74,999
R13 · FY2020 · OD · contact PI
Non-human Primates Facilities to Support HIV/AIDS-related Research$2,999,996
C06 · FY2019 · OD · contact PI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE$809,993
R01 · FY2019 · AI · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$1,311,373
R01 · FY2018 · HD · contact PI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE$819,113
R01 · FY2018 · AI · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$1,215,319
R01 · FY2017 · HD · contact PI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE$816,746
R01 · FY2017 · AI · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$1,234,993
R01 · FY2016 · HD · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$1,194,483
R01 · FY2015 · HD · contact PI
Technological and Physical Enhancements for Primate Behavioral Testing Suites$497,794
G20 · FY2015 · OD · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$1,699,333
P01 · FY2014 · AI · contact PI
Reducing Latent Viral Reservoirs in Infant Macaques$941,882
R01 · FY2014 · HD · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$354,651
P01 · FY2014 · AI · contact PI
Administration and Biostatistics$152,702
P01 · FY2014 · AI · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$2,268,093
P01 · FY2013 · AI · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$431,684
P01 · FY2013 · AI · contact PI
Administration and Biostatistics$117,548
P01 · FY2013 · AI · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$2,175,494
P01 · FY2012 · AI · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$556,685
P01 · FY2012 · AI · contact PI
Immunology$208,515
P30 · FY2012 · AI · contact PI
Administration and Biostatistics$56,826
P01 · FY2012 · AI · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$1,924,641
P01 · FY2011 · AI · contact PI
EDUCATIONAL ACTIVITIES AND TRAINING$606,194
P51 · FY2011 · RR · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$513,861
P01 · FY2011 · AI · contact PI
PROGRAMMING HIV IMMUNITY FOR BROADLY NEUTRALIZING ANTIBODIES BY VACCINATION$365,216
P51 · FY2011 · RR · contact PI
Novel antigen display system to present multiple antigens HIV vaccines$350,609
R01 · FY2011 · AI · contact PI
Immunology$326,122
P30 · FY2011 · AI · contact PI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$194,877
P51 · FY2011 · RR · contact PI
NOVEL ANTIGEN DISPLAY SYSTEM TO PRESENT MULTIPLE ANTIGENS AS HIV VACCINES$194,877
P51 · FY2011 · RR · contact PI
ANALYZING THE HIV-SPECIFIC NEUTRALIZING ANTIBODY RESPONSE AND REPERTOIRE$194,877
P51 · FY2011 · RR · contact PI
ROLE OF NEUTRALIZING ANTIBODIES IN TRANSMISSION OF SHIV$194,877
P51 · FY2011 · RR · contact PI
Administration and Biostatistics$106,428
P01 · FY2011 · AI · contact PI
DIRECTOR'S OFFICE$80,062
P51 · FY2011 · RR · contact PI
PROOF OF CONCEPT FOR CARD-BASED CD4 CELL COUNTING$60,826
P51 · FY2011 · RR · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$2,021,024
P01 · FY2010 · AI · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$577,606
P01 · FY2010 · AI · contact PI
NEUTRALIZING ANTIBODIES FOR HIV VACCINES$380,402
P51 · FY2010 · RR · contact PI
Novel antigen display system to present multiple antigens HIV vaccines$354,150
R01 · FY2010 · AI · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$313,000
R01 · FY2010 · HD · contact PI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$190,131
P51 · FY2010 · RR · contact PI
Immunology$177,142
P30 · FY2010 · AI · contact PI
NOVEL ANTIGEN DISPLAY SYSTEM TO PRESENT MULTIPLE ANTIGENS AS HIV VACCINES$152,161
P51 · FY2010 · RR · contact PI
ANALYZING THE HIV-SPECIFIC NEUTRALIZING ANTIBODY RESPONSE AND REPERTOIRE$152,161
P51 · FY2010 · RR · contact PI
Administration and Biostatistics$114,438
P01 · FY2010 · AI · contact PI
PROOF OF CONCEPT FOR CARD-BASED CD4 CELL COUNTING$114,051
P51 · FY2010 · RR · contact PI
DUAL SUBTYPE QUASISPECIES ENVELOPE SHIV VACCINE$95,066
P51 · FY2010 · RR · contact PI
PROGRAMMING HIV IMMUNITY FOR BROADLY NEUTRALIZING ANTIBODIES BY VACCINATION$95,066
P51 · FY2010 · RR · contact PI
EDUCATIONAL ACTIVITIES AND TRAINING$47,603
P51 · FY2010 · RR · contact PI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination$2,022,567
P01 · FY2009 · AI · contact PI
Vaccination design based on natural env genes to elicit broad neutralizing Abs$529,800
P01 · FY2009 · AI · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$497,587
R01 · FY2009 · HD · contact PI
Novel antigen display system to present multiple antigens HIV vaccines$357,727
R01 · FY2009 · AI · contact PI
ROLE OF NEUTRALIZING ANTIBODIES IN TRANSMISSION OF SHIV$331,393
P51 · FY2009 · RR · contact PI
Immunology$189,349
P30 · FY2009 · AI · contact PI
PROGRAMMING$165,284
P51 · FY2009 · RR · contact PI
NOVEL ANTIGEN DISPLAY SYSTEM TO PRESENT MULTIPLE ANTIGENS AS HIV VACCINES$165,284
P51 · FY2009 · RR · contact PI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$165,284
P51 · FY2009 · RR · contact PI
PROOF OF CONCEPT FOR CARD-BASED CD4 CELL COUNTING$124,031
P51 · FY2009 · RR · contact PI
Administration and Biostatistics$123,744
P01 · FY2009 · AI · contact PI
DUAL SUBTYPE QUASISPECIES ENVELOPE SHIV VACCINE$103,268
P51 · FY2009 · RR · contact PI
EDUCATIONAL ACTIVITIES AND STAFF TRAINING$51,566
P51 · FY2009 · RR · contact PI
Small Group Housing for SPF Monkeys$488,853
G20 · FY2008 · RR · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$413,771
R01 · FY2008 · HD · contact PI
Novel antigen display system to present multiple antigens HIV vaccines$357,727
R01 · FY2008 · AI · contact PI
Immunology$188,311
P30 · FY2008 · AI · contact PI
DUAL SUBTYPE QUASISPECIES ENVELOPE SHIV VACCINE$176,141
P51 · FY2008 · RR · contact PI
NOVEL ANTIGEN DISPLAY SYSTEM TO PRESENT MULTIPLE ANTIGENS AS HIV VACCINES$176,141
P51 · FY2008 · RR · contact PI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$176,141
P51 · FY2008 · RR · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$110,291
R01 · FY2008 · HD · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$517,305
R01 · FY2007 · HD · contact PI
Novel antigen display system to present multiple antigens HIV vaccines$446,839
R01 · FY2007 · AI · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$494,682
R01 · FY2006 · HD · contact PI
E2 Display as a candidate AIDS vaccine$229,117
R21 · FY2006 · AI · contact PI
ROLE OF NEUTRALIZING ANTIBODIES IN TRANSMISSION OF SHIV$228,467
P51 · FY2006 · RR · contact PI
Role of Neutralizing Antibodies in Transmission of SHIV$366,758
R01 · FY2005 · HD
Core-Molecular Immunology$108,566
P30 · FY2004 · AI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$100,001
R01 · FY2004 · HD
FIBROCYTES AS ANTIGEN PRESENTING CELLS FOR AIDS VACCINES$189,414
P51 · FY2003 · RR
PERINATAL TRANSMISSION OF PATHOGENIC SHIV$189,414
P51 · FY2003 · RR
DNA VACCINES FOR SHIV IN M. NEMESTRINA$121,816
P51 · FY2003 · RR
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$346,624
R01 · FY2002 · HD
BROADENING HOST IMMUNITY WITH DNA BASED QUASISPECIES VACCINES$0
P01 · FY2002 · AI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$336,305
R01 · FY2001 · HD
DNA BASED VACCINES FOR HIV &SIV$0
P51 · FY2001 · RR
PASSIVE IGG THERAPY IN SIV INFECTED MACAQUES$0
P51 · FY2001 · RR
BROADENING HOST IMMUNITY WITH DNA BASED QUASISPECIES VACCINES$0
P01 · FY2001 · AI
ROLE OF ANTIBODY IN PERINATAL TRANSMISSION OF SHIV$350,408
R01 · FY2000 · HD
BROADENING HOST IMMUNITY WITH DNA BASED QUASISPECIES VACCINES$343,350
P01 · FY2000 · AI